BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33768227)

  • 1. Breast Milk Antibody Levels in Tdap-Vaccinated Women After Preterm Delivery.
    Orije MRP; Larivière Y; Herzog SA; Mahieu LM; Van Damme P; Leuridan E; Maertens K
    Clin Infect Dis; 2021 Sep; 73(6):e1305-e1313. PubMed ID: 33768227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The induction of breast milk pertussis specific antibodies following gestational tetanus-diphtheria-acellular pertussis vaccination.
    Abu Raya B; Srugo I; Kessel A; Peterman M; Bader D; Peri R; Ashtamker N; Gonen R; Bamberger E
    Vaccine; 2014 Sep; 32(43):5632-7. PubMed ID: 25148774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pertussis Immunization During Pregnancy: Assessment of the Role of Maternal Antibodies on Immune Responses in Term and Preterm-Born Infants.
    Maertens K; Orije MRP; Herzog SA; Mahieu LM; Hens N; Van Damme P; Leuridan E
    Clin Infect Dis; 2022 Jan; 74(2):189-198. PubMed ID: 33971009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pertussis antibody levels in infants and their mothers receiving combined tetanus-diphtheria toxoid and acellular pertussis vaccine during pregnancy in Turkey.
    Ozdil M; Sonmez C; Tugberk Bakar M; Alici Davutoglu E; Madazli R; Kilic S; Vural M; Perk Y
    Eur J Obstet Gynecol Reprod Biol; 2021 Oct; 265():212-216. PubMed ID: 34534737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of pertussis, tetanus, and diphtheria antibodies in sera and breast milk from Tdap vaccinated women using a qualified multiplex assay.
    Portillo S; Oshinsky J; Williams M; Yoder S; Liang Y; Campbell JD; Laufer MK; Neuzil KM; Edwards KM; Pasetti MF
    mSphere; 2024 Apr; 9(4):e0052723. PubMed ID: 38497618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study protocol of the PIMPI-project, a cohort study on acceptance, tolerability and immunogenicity of second trimester maternal pertussis immunization in relation to term and preterm infants.
    Immink MM; Bekker MN; de Melker HE; Rots NY; Sanders EAM; van der Maas NAT
    BMC Infect Dis; 2021 Sep; 21(1):897. PubMed ID: 34479491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Effect of Timing of Tetanus-Diphtheria-Acellular Pertussis Vaccine Administration in Pregnancy on the Avidity of Pertussis Antibodies.
    Abu-Raya B; Giles ML; Kollmann TR; Sadarangani M
    Front Immunol; 2019; 10():2423. PubMed ID: 31681310
    [No Abstract]   [Full Text] [Related]  

  • 8. Kinetics of maternal pertussis-specific antibodies in infants of mothers vaccinated with tetanus, diphtheria and acellular pertussis (Tdap) during pregnancy.
    Healy CM; Rench MA; Swaim LS; Timmins A; Vyas A; Sangi-Haghpeykar H; Ng N; Rajam G; ; Havers F; Schiffer J; Baker CJ
    Vaccine; 2020 Aug; 38(37):5955-5961. PubMed ID: 32709433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Maternal Pertussis Antibodies on the Infants' Cellular Immune Responses.
    Orije MRP; García-Fogeda I; Van Dyck W; Corbière V; Mascart F; Mahieu L; Hens N; Van Damme P; Cools N; Ogunjimi B; Maertens K; Leuridan E
    Clin Infect Dis; 2022 Aug; 75(3):442-452. PubMed ID: 34849638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
    Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
    Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seroprevalence of Bordetella pertussis antibodies and anti-pertussis antibody response after a single dose of reduced-antigen combined diphtheria, tetanus, and acellular pertussis vaccine (Tdap) in pregnant Thai women.
    Sompagdee N; Anuwutnavin S; Phongsamart W; Senawong S; Umrod P; Robkhonburi A
    Vaccine; 2020 Mar; 38(12):2725-2733. PubMed ID: 32070680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pertussis antibodies and vaccination coverage among healthcare professionals in Brazil is inadequate: A cross-sectional serological study.
    Cardona RSB; Weckx LY; de Moraes-Pinto MI; Ramos BCF; Dos Santos ARA; Spina FG; de Araújo BC; Clemens R; Clemens SAC
    Vaccine; 2023 Sep; 41(39):5769-5774. PubMed ID: 37573201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Importance of timing of maternal combined tetanus, diphtheria, and acellular pertussis (Tdap) immunization and protection of young infants.
    Healy CM; Rench MA; Baker CJ
    Clin Infect Dis; 2013 Feb; 56(4):539-44. PubMed ID: 23097585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal pertussis vaccination and its effects on the immune response of infants aged up to 12 months in the Netherlands: an open-label, parallel, randomised controlled trial.
    Barug D; Pronk I; van Houten MA; Versteegh FGA; Knol MJ; van de Kassteele J; Berbers GAM; Sanders EAM; Rots NY
    Lancet Infect Dis; 2019 Apr; 19(4):392-401. PubMed ID: 30938299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the timing of maternal vaccination and newborns' anti-pertussis toxin antibody levels.
    Vaz-de-Lima LRA; Sato HK; Fernandes EG; Sato APS; Pawloski LC; Tondella ML; de Brito CA; Luna EJA; Carvalhanas TRMP; de Castilho EA;
    Vaccine; 2019 Aug; 37(36):5474-5480. PubMed ID: 31153689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tdap vaccine in pregnancy and immunogenicity of pertussis and pneumococcal vaccines in children: What is the impact of different immunization schedules?
    Febriani Y; Mansour T; Sadarangani M; Ulanova M; Amaral K; Halperin SA; De Serres G; Racine É; Brousseau N
    Vaccine; 2023 Oct; 41(45):6745-6753. PubMed ID: 37816653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study.
    Abu Raya B; Srugo I; Kessel A; Peterman M; Bader D; Gonen R; Bamberger E
    Vaccine; 2014 Oct; 32(44):5787-93. PubMed ID: 25173476
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of maternal Tdap on infant antibody response to a primary vaccination series with whole cell pertussis vaccine in São Paulo, Brazil.
    Vaz-de-Lima LRA; Sato APS; Pawloski LC; Fernandes EG; Rajam G; Sato HK; Patel D; Li H; de Castilho EA; Tondella ML; Schiffer J;
    Vaccine X; 2021 Apr; 7():100087. PubMed ID: 33817624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
    Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
    Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and Safety of Monovalent Acellular Pertussis Vaccine at Birth: A Randomized Clinical Trial.
    Wood N; Nolan T; Marshall H; Richmond P; Gibbs E; Perrett K; McIntyre P
    JAMA Pediatr; 2018 Nov; 172(11):1045-1052. PubMed ID: 30208475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.